Gates Package — page 41

To: Marshall Hoke <{§@cbrintl.com<mailto {MO cbrintl.com>>, Larry Zeitlin EEEEE© a ppbio.com<mailto {BO mappbio.com>>, Trina Racine <trina.racine@phacaspc.gc.ca<mailto:trina.racine@phac-aspc.gc.ca>>, deborah scott sbcglobal.net<mailto NO sbcelobal.net>> Ce: "Gary (Public Health Agency of Canada) Kobinger" {EP phac-aspc.gc.cacmailto: ENN phacaspc.gc.ca>>, EEO nih.cov<mailto HO nih.gov> [C] Olinger" nih.gov>>, "Peter (NIH/NIAID) [E] Jahrling" niaid.nih.govsmailto niaid.nih.gov>>, Mike Hensley icloud.com<mailto icloud.com>>, "Lisa (NIH/NIAID) [E] Hensley" nih.gov<mailto JO nih.gov>>, Miles Brennan ; Seg cbrintl.com<mailto: cbrintl.com>>, Tara Nyhuis ericoccrcnc ge icone: "Shindo, Nikki" <JO who. int<mailto {FO who.int>>, '2 gmail.com<mailto I gmail.com>" ERE em ail.com<mailto BO email.com>>, EO who. int<mailto fjowho int>" Eo who. int<mailto fowho int>>, 'Owho int<mailto IO who int>" EEC 10 intailto MO whe int=>, fe who. int<mailto ge who int>" Eo who. int<mailto fjowho .int>> Date: 2014-08-03 03:12 AM Subject: RE: Combining the existing Phase 1 with a Therapeutic Portion Dear Colleagues, I am writing on behalf of the Ebola clinical management team at WHO and am forwarding this working version of a document on potential therapeutics. Comments, corrections, and additions are welcome- forward these to Aaruni Saxena, Nikki Shindo, and me at your earliest opportunity. Please note that this document is a draft and should be held in confidence. Thanks for your help, fgh From: Marshall Hoke (6 cbrintl.com<mailto Fe cbrint!.com>] Sent: 31 July 2014 22:24 To: Larry Zeitlin; Trina Racine; deborah scott Cc: Hayden, Frederick G *HS; Gary (Public Health Agency of Canada) Kobinger; nih.gov<mailto {BO nih.gov> [C] Olinger; Peter (NIH/NIAID) [E] Jahrling; Mike Hensley; Lisa (NIH/NIAID) [E] Hensley; Miles Brennan; Tara Nyhuis Subject: RE: Combining the existing Phase 1 with a Therapeutic Portion Dear All, Due to limited availability tomorrow, we would like to postpone our discussion until next Tuesday (8/5/14) at 7 AM PDT/ 8 AM MDT/ 9AM CDT/ 10 AM EDT/ 4 PM CEST. We will distribute an agenda and dial-in information on Monday, and please let us know of any questions or requests in the meantime. Thank you, Marshall Marshall Hoke, B.A. Technical Associate CBR International Corp. (r)